A collaboration of researchers from Harvard Medical School and the University of Virginia, led by Dr. Anindya Dutta, has created an artificial mammalian origin of replication that will facilitate the future study of mammalian DNA replication.
Dr. Dutta and colleagues recruited known mammalian replication initiation factors (either ORC or CDC6) to a defined GAL4 DNA-binding site on a plasmid, demonstrating that replication initiation factor recruitment is sufficient to specify a DNA replication origin.
The researchers have extended the classic transcription factor reporter assay to work for any eukaryotic replication initiation factor. The artificial mammalian replication origin will enable scientists to explore the mechanism of replication initiation, as well as "provide a new direction for creating vectors for gene therapy that are less mutagenic than current integrating vectors and that do not require viral proteins," explains Dr. Dutta.
Heather Cosel | Source: EurekAlert!
Further information: www.cshl.edu
More articles from
Life Sciences:
Atomic-resolution views suggest function of enzyme that regulates light-detecting signals in eye
09.10.2008 | University of Washington
What causes cell defences to crumble? - Researchers identify proteins in mussels that act as a barrier to chemicals
09.10.2008 | Helmholtz-Zentrums fuer Umweltforschung (UFZ)
Arctic soil reveals climate change clues
09.10.2008 | Earth Sciences
09.10.2008 | Health and Medicine
Atomic-resolution views suggest function of enzyme that regulates light-detecting signals in eye
09.10.2008 | Life Sciences